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JunDBAG3 plays a regulatory role in a number of cellular processes, including cell proliferation, apoptosis, adhesion
and migration, epithelial–mesenchymal transition (EMT), autophagy activation, and virus infection. The AP-1
transcription factors are implicated in a variety of important biological processes including cell differentiation,
proliferation, apoptosis and oncogenesis. Recently, it has been reported that AP-1 protein c-Jun inhibits
autophagy and enhances apoptotic cell death mediated by starvation. However, the molecular mechanisms
remain unclear. For the ﬁrst time, the current study demonstrated that serum starvation downregulated
BAG3 at the transcriptional level via c-Jun. In addition, the current study reported that BAG3 stabilized JunD
mRNA,whichwas, at least in part, responsible for the promotion of serum starvationmediated-growth inhibition
by BAG3.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bcl-2-associated athanogene 3 (BAG3) is a member of the BAG
domain containing co-chaperone family, which is characterized by
interaction with a variety of partners, such as heat shock proteins
(HSPs), Bcl-2, Raf, and steroid hormone receptors [1–3]. BAG3 affects a
number of cellular processes, including cell proliferation, apoptosis,
adhesion and migration [4]. BAG3 also interacts with HSPB8 and
controls the degradation of misfolded protein [5–9]. Furthermore, very
recently we have reported a novel role ascribed to BAG3 in controlling
epithelial–mesenchymal transition (EMT) [10]. BAG3 is shown to be
induced upon cellular stress such as exposure to high temperature
[11,12], heavy metals [11], oxidants [13–15], HIV infection [16,17],
and proteasome inhibition [14]. Several studies also demonstrate
that BAG3 expression is upregulated and acts as a pro-survival and
anti-apoptotic protein in cancer cells derived from various histology
[18–22].erest that could be perceived
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Wang).
ights reserved.The Jun proteins (c-Jun, JunB, and JunD) are basic-leucine transcrip-
tion factors that can form either AP-1 homodimers (Jun/Jun) or AP-1
heterodimers with members of the related Fos family (c-Fos, FosB,
Fra-1 and Fra-2) or the ATF/CREB (ATF1-4, ATF6, β-ATF and ATFx)
family or JDP (JDP2) family [23–26]. The AP-1 complexes play a role
in either transcriptional activation or repression, and may be func-
tionally distinct to regulate a number of cellular processes including
oncogenesis [27,28]. The JunD gene is the most new member of the
Jun family, which was initially identiﬁed in a screen of a cDNA
library from mouse 3T3 cells [29]. Similarly to other Jun proteins,
JunD transactivates the AP-1-responsive promoter in combination
with c-Fos or Jun proteins [29]. However, JunD is signiﬁcantly different
from the other Jun proteins. Firstly, the expression pattern of JunD
diverges from the immediate early response genes c-jun and JunB,
which are mitogenic stimuli-inducible [29,30]. JunD transcription is
constitutive in quiescent cells and is rarely affected by growth factors
[30]. In addition, JunD has longer half-life relative to c-Jun (360
and 90 min, respectively), which may be ascribed to inefﬁcient
ubiquitination of JunD in spite of the presence of a δ-like domain
[31,32]. c-Jun and JunB are positive AP-1 factors and their activation
promotes the transition from a quiescent state to proliferative state. In
contrast, JunD functions as a negative AP-1 factor and its activation
generally is considered to suppress cell proliferation [30,33,34].
Furthermore, studies on transgenic mice demonstrated that c-Jun and
JunB are essential for embryonic development, whereas JunD is
dispensable for mammalian development [35]. Taken together, these
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possible function for JunD in relation to c-Jun and JunB [30].
The current study for the ﬁrst time demonstrated that BAG3may lie
in the feedback loop of AP-1. At ﬁrst, c-Jun is implicated in BAG3 gene
expression via direct interaction with its promoter. Serum deprivation
suppressed BAG3 expression at the transcriptional level via reduction
of c-Jun. Second, ectopic BAG3 expression promoted growth arrest
mediated by serum deprivation via stabilization of JunD mRNA. As
c-Jun and JunD are generally considered as positive and negative AP-1
factors, respectively [30,33,34]. The current study implies a potential
role of BAG3 in a counter-balancing feedback loop to regulate AP-1.
2. Materials and methods
2.1. Culture of multiple cancer cell lines
HEK293, HepG2, LK87, MCF7, U87 and FRO cell lines were
maintained in DMEM (Sigma-Aldrich, Saint Louis, MO) supplemented
with 10% fetal bovine serum (FBS, Sigma-Aldrich, Saint Louis, MO).
2.2. Cell viability assays
For cell viability assays, cells were plated in 96-well dishes (1×104
cells per well) and treated with FBS free medium for the indicated
time. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-
thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Chemicon,
Bedford, MA) according to the manufacturer's instruction.
2.3. Detection of cell death
For cell death assays, cellswerewashed twice in phosphate-buffered
saline and then stained with Annexin V-FITC (Biovision, Mountainview,
CA) and propidium iodide (PI, Sigma-Aldrich) according to the
manufacturer's instructions. After staining with annexin V-FITC and
PI, samples were analyzed by ﬂuorescence-activated cell scanner
(FACScan) ﬂow cytometer (Becton Dickinson, Franklin Lakes, NJ).
2.4. Chromosomal immunoprecipitation (ChIP) assay
ChIP analysis was performed as described previously [22]. PCR
was performed using primers speciﬁc for human BAG3 sequence
between −186 and +96 (forward: 5′-AGTCCAGCTCGTCCGGCTTC-3′
and reverse: 5′-GGTAGCAACTGGCCGGCTAG-3′) to generate a 282 bp
ampliﬁcation product containing potential c-Jun-binding sequence.
The PCR products were run on 1.5% agarose gels containing ethidium
bromide followed by visualization under UV.
2.5. Gene expression microarray
Mock and BAG3 overexpression FRO cells were used for analysis of
differential gene expression using the Affymetrix™ Canine v2.0 gene
chip. Brieﬂy, cells in log-phase growth were harvested. RNA was
extracted using the Qiashredder and RNeasy Kit form Qiagen (Valencia,
CA). RNA quantity and integrity were assessed using the Nanodrop
1000 (ThermoScientiﬁc, Waltham, MA) and Bioanalyzer (Agilent
Technologies, Foster City, CA) respectively. Resulting RNA was used
for ﬁrst- and second-strand cDNA synthesis followed by cDNA cleanup
and overnight in vitro transcription. Following cDNA cleanup and
fragmentation steps, samples were then hybridized to the Affymetrix
chip and scanned.
2.6. Analysis of the cell cycle by ﬂow cytometry
Cells were cultured in FBS free medium for the indicated time. The
cells were ﬁxed in 70% ethanol and stained with 50μg/ml of propidium
iodide (PI). The ﬂuorescence wasmeasured using the Becton DickinsonFACScan (Bedford, MA). Distribution of cells in distinct cell cycle phase
was determined using ModFIT cell cycle analysis software.
2.7. RNA isolation and real-time reverse transcription-polymerase chain
reaction (RT-PCR)
RNA isolation and real-time RT-PCR were performed as previously
reported [36]. For BAG3, the forward primer was 5′-CATCCAGGAG
TGCTGAAAGTG-3′ and reverse was 5′-TCTGAACCTTCCTGACACCG-3′.
For JunD, the forward primer was 5′-TTTGGAAGAGAGAAGAACAGAG-3′
and reverse was 5′-CCAAGGATTACAAACAGGAATG-3′. For β-actin, the
forward primer was 5′-GAGACCTTCAACACCCCAGCC-3′ and the re-
verse was 5′-GGATCTTCATGAGGTAGTCAG-3′. Results were normalized
against those of β-actin and presented as arbitrary unit.
2.8. Western blot analysis
Cells were lysed in lysis buffer (20mMTris–HCl, 150mMNaCl, 2mM
EDTA, 1% Triton-X100 and protease inhibitor cocktail (Sigma-Aldrich,
Saint Louis, MO). Cell extract protein amounts were quantiﬁed using
the BSA protein assay kit. Equivalent amounts of protein (25 μg) were
separated using 12% SDS–PAGE and transferred to PVDF membrane
(Millipore Corporation, Billerica, MA).
2.9. Construction of BAG3 plasmid and cell transfection
BAG3 constructs were generated as previously reported [37]. Cells
were transfected with Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA) as instructed by the supplier. Stable clonal cell lines
were selected with 1mg/ml G418, and were maintained at 0.2 mg/ml
G418. Wild type (WT) c-Jun and DBD mutant c-Jun that is capable of
binding DNA were generated as previously described [38] and
generously provided by Professor Eitan Shaulian (Hebrew University
Medical School, Israel).
2.10. Label and capture nascent RNA
Newly synthesized RNA was isolated using Click-iT Nascent RNA
Capture Kit (Invitrogen, C10365) according to the manufacturer's
instruction. Brieﬂy, cells were incubated in 0.2mMof 5-ethymyl uridine
(EU, an alkyne-modiﬁed uridine analog, which is efﬁciently and
naturally incorporated into the nascent RNA) for 4 h and total RNA
labeled with EU was isolated using TRIzol reagent (Invitrogen, 15596-
018). Then EU-labeled RNAwas biotinylated in a Click-iT reaction buffer
with 0.5mM of Biotin azide and subsequently captured on streptavidin
magnetic beads.
2.11. Small interfering RNA (siRNA)
The siRNA sequences used here were as follows: siRNA against
JunD (siJunD), #1, CCCUCAAGAGUCAGAACACdTdT; #2, GCCGCCUCC
AAGUGCCGCAdTdT; #3, GCAGCUCAAGCAGAAAGUCdTdT. The scramble
nonsense siRNA (scramble; UUCUCCGAACGUGUCACGUTT) that has
no homology to any known genes was used as control. Transfection
of siRNA oligonucleotide was performed with Lipofectamine
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's
recommendations.
2.12. Statistics
The statistical signiﬁcance of the difference was analyzed by ANOVA
and post hoc Dunnett's test. Statistical signiﬁcance was deﬁned as
Pb0.05.
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3.1. Serum starvation downregulates the expression of BAG3
LK87 cells were grown to 80% conﬂuence in DMEM containing 10%
FBS. These cells were washed with PBS three times and were fed with
media with different concentrations of FBS or EBSS for 8h, quantitative
RT-PCR (Fig. 1A) and Western blot (Fig. 1B) demonstrated that BAG3A
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Fig. 1. Reduction of BAG3 expression upon serum deprivation. A–B, Lung cancer LK87 cells we
expressionwas analyzedusing real time RT-PCR andWestern blot analysis, respectively. C–D, LK
mRNA (C) and protein (D) expressionwas analyzedusing real timeRT-PCRandWesternblot an
time; BAG3mRNA (E) and protein (F) were analyzed using real time RT-PCR andWestern blot
10% FBS for 8 h; BAG3 mRNA (G) and protein (H) were analyzed using real time RT-PCR and WmRNA and protein were decreased in a dose-dependent manner upon
serum deprivation. Glucose deprivation demonstrated no obvious effect
on BAG3 expression at bothmRNA (Fig. 1C) and protein (Fig. 1D) levels.
Quantitative RT-PCR demonstrated that BAG3 mRNA was signiﬁcantly
decreased 2 h post-serum deprivation, and reached the lowest level at
12h and 24h (Fig. 1E). Consistent with the expression of BAG3 mRNA,
BAG3 protein was marginally reduced at 4 h after serum deprivation
and reached high suppressive at 12 and 24 h of serum deprivationB
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different cell lines, including HEK293, FRO, U87, MCF7, and HepG2 cells
(Fig. 1G and H).
3.2. Serum-deprivation decreases BAG3 at the transcriptional level via
reduction of c-Jun
To test the possibility that the decrease in BAG3 mRNA level upon
serum deprivation is due to a reduction of mRNA synthesis, novel
BAG3 gene transcription was analyzed using Click-iT Nascent RNA
Capture (Life Technology) to label and isolate newly synthesized RNA.
Quantitative RT-PCR demonstrated that serum deprivation decreased
novel BAG3 mRNA level (Fig. 2A), indicating that serum deprivation
suppressed transcriptional activation of BAG3 gene.
Using in silico analysis a putative c-Jun/c-Fos binding site
(GATGATCAG) was found at −10/−2 region (+1 represents the
transcriptional start site) of the BAG3 promoter. In addition, c-Jun
expression is reduced by starvation [39], and JNK is implicated in
the inducible expression of BAG3 [21]. These prompted us to inves-
tigate whether c-Jun is implicated in serum deprivation-mediated
reduction of BAG3 expression. Firstly, ChIP analysis was performed
and demonstrated that c-Jun interacted with the promoter sequence
of BAG3 gene, whereas rabbit IgG antibody controls did not (Fig. 2B).
c-Jun antibody could not precipitate the promoter of GAPDH gene,
excluding the nonspeciﬁc precipitation by the c-Jun antibody (Fig. 2B).A
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as a negative control and immunoprecipitated DNAwas ampliﬁed by PCR. The experimentswer
for the indicated time, andWestern blotwas performedusing the indicated antibodies. D,HEK29
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deﬁcient (DBD) c-Jun vector for 24 h, then cells were cultured in complete media or serum-fr
BAG3 mRNA and protein, respectively. *, P b 0.01.Consistent with previous report [39], serum deprivation resulted
in time-dependent reduction of c-Jun expression, c-Jun was reduced
at 2 h and undetectable at 8 h (Fig. 2C). It should be noted that reduc-
tion of c-Jun occurred before downregulation of BAG3 upon serum
deprivation (Fig. 2C). Serum deprivation also decreased JunB and
c-Fos expression, while demonstrated no obvious effect on JunD
expression (Fig. 2C). ChIP analysis conﬁrmed that the recruitment of
c-Jun to the BAG3 promoter was signiﬁcantly blocked upon serum
starvation (Fig. 2D). To further conﬁrm the involvement of c-Jun in
serum deprivation-mediated downregulation of BAG3, we transfected
HEK293 cells with wild type (WT) c-Jun or DNA binding-deﬁcient
(DBD) c-Jun eukaryotic expression vector [38], and found that WT
c-Jun increased BAG3 mRNA (Fig. 2E) and protein (Fig. 2F) expression
levels under normal culture condition, while DBD c-Jun demonstrated
little effect (Fig. 2E and F). Importantly, WT c-Jun still increased
BAG3 expression under condition of serum deprivation (Fig. 2E
and F). On the other hand, DBD c-Jun demonstrated no effect on serum
deprivation-mediated reduction of BAG3 expression (Fig. 2E and F).
3.3. BAG3 overexpression sensitizes cells to serum deprivation-induced
growth arrest
To investigate the potential effect of BAG3 on growth inhibition
induced by serum deprivation, cells were transfected with BAG3
eukaryotic expression vector, and stable clones were selected. MTTIn
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niﬁcantly promoted reduction of cell viability mediated by serum
deprivation in U87 (Fig. 3A), MCF7 (Fig. 3B), and FRO (Fig. 3C) cells.
Cell cycle analyses demonstrated that serum deprivation caused the
cell cycle arrest in the G1 phase in U87 cells (Fig. 3D). However, serum
deprivation arrested BAG3-overexpressed U87 cells at G2-M transition,
accordingly, distribution in G1 phase was signiﬁcantly decreased
(Fig. 3D). Similar effects of BAG3 on cell cycle distribution were also
observed in MCF7 (Fig. 3E) and FRO cells (Fig. 3F).
Analyses of apoptotic cell death using Annexin V/PI double staining
followed by ﬂow cytometry demonstrated that no obvious apoptosis
occurred in nontransfected U87, MCF7 and FRO cells after 24 h of
serum deprivation (Fig. 3G). BAG3 increased apoptotic cell death
induced by serum deprivation inMCF7 and FRO cells, but demonstrated
no obvious effect in U87 cells (Fig. 3G).0 30 60 90 120 150
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To clarify the mechanism(s) by which BAG3 overexpression
promoted growth inhibition mediated by serum deprivation, we used
a microarray approach (Affymetrix GeneChip) to search for molecular
markers. Among the altered genes, we focused on the transcripts
encoding JunD, which were signiﬁcantly increased in FRO cells
overexpressing BAG3. Consistent with the GeneChip data, real time
PCR conﬁrmed increased expression of JunD in FRO transfected with
BAG3, but not empty control plasmid (Fig. 4A). The increase in ex-
pression of JunD protein was also conﬁrmed by Western blot analysis
(Fig. 4B). The steady-state levels of JunD protein also increased
signiﬁcantly in FRO, MCF7 and U87 cells stably overexpressing BAG3
(Fig. 4C). To test the possibility that the increase in JunD mRNA level
in BAG3-overexpressed cells results from an increase in mRNA120 150
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3351C. Li et al. / Biochimica et Biophysica Acta 1833 (2013) 3346–3354synthesis, we examined changes in the rate of nascent JunD mRNA
using Click-iT Nascent RNA Capture to label and isolate newly
synthesized RNA. Real-time PCR demonstrated that there were no
signiﬁcant differences in the rate of JunD gene transcription between
control cells and BAG3-overexpressed cells (Fig. 4D). To determine the
involvement of posttranscriptional regulation in this process, JunD
mRNA stability was examined by measurement of the mRNA half-life
using actinomycin D1. In control cells, JunD mRNA levels declined
rapidly after inhibition of gene transcription by addition of actinomycin
D (Fig. 4E). The half-life of JunD mRNA in control cells was about 1 h.
However, the stability of JunD mRNA was signiﬁcantly increased in
BAG3 cells with a half-life of N6h (Fig. 4E).
To further conﬁrm the potential involvement of BAG3 in JunD
regulation, BAG3 was downregulated by shRNA speciﬁc against BAG3
(shBAG3). Two independent BAG3 shRNA (shBAG3#2 and shBAG3#4)
signiﬁcantly decreased BAG3 expression (Fig. 4F). Importantly, knock-
down of BAG3 also signiﬁcantly reduced JunD expression (Fig. 4F).
3.5. JunD is responsible for the enhancing effect of BAG3 on growth
inhibition induced by serum deprivation
To test the involvement of JunD in the promotion of serum
deprivation-mediated growth inhibition by BAG3, we selectively
knocked down its mRNA by RNA interference in stably BAG3
overexpressing FRO (FRO-BAG3) cells. Real-time RT-PCR (Fig. 5A) and
Western blot analysis (Fig. 5B) veriﬁed that the efﬁcacy of silencing of
JunD mRNA and protein by two independent non-overlapping siRNAs
(#1 and #3) was more than 80% and 70%, respectively. We thenchose the two siRNAs for use in the subsequent experiments. MTT
assays demonstrated that JunD-silenced FRO-BAG3 cells were more
resistant to serum deprivation than the corresponding control siRNA-
transfected cells (Fig. 5C). Cell cycle analyses demonstrated that knock-
down of JunD signiﬁcantly increased cells distributed in G1 phase,while
decreased cells distributed in G2-M phase, when compared with parent
or control siRNA-transfected FRO-BAG3 cells after 24 h of serum
starvation (Fig. 5D).
4. Discussion
The Jun proteins (c-Jun, JunB, and JunD) can both homodimerize and
heterodimerize with Fos or ATF/CREB members to form transcrip-
tionally active AP-1 complexes. Different combinations of AP-1 com-
ponents have been involved in a wide range of cellular processes,
including cell proliferation, differentiation, apoptosis, transformation,
metastasis and angiogenesis [27,40]. Despite structural similarities
among c-Jun, JunB, and JunD, it has been shown that JunD is an atypical
member of AP-1 and exhibits distinct biological properties. Unlikewell-
characterized growth factor-inducible fashion of the early response
genes c-Jun and JunB, expression of the JunD gene is generally
constitutive and is rarely affected by growth factors and external stimuli
[30]. c-Jun and JunB are positive AP-1 factors and its activation generally
is believed to promote cell proliferation, in contrast, JunD functions as a
negative AP-1 factor and its activation generally is considered to inhibit
cell proliferation [30,33,34]. The current study for the ﬁrst time,
reported that BAG3 is closely related with Jun proteins: on one hand,
BAG3 is positively regulated by c-Jun; on the other hand, BAG3 stabilizes
AC
Ju
nD
 m
RN
A
(ra
tio
 vs
 FR
O)
FR
O
m
oc
k-
FR
O BA
G3
-
FR
O
0
2
4
6
8
10
FR
O FR
O
-
m
oc
k FR
O
-
BA
G3
BAG3
JunD
γ-tubulin
B
n
a
sc
en
t J
un
D 
m
RN
A
(ra
tio
 vs
 FR
O)
FR
O FR
O
-
m
oc
k FR
O
-
BA
G3
0
2
1
0
20
40
60
80
100
120
0h 0.5h 1h 2h 4h 6h 8h
FRO
FRO-BAG3
Ju
nD
 m
RN
A 
(%
 of
 0h
)
D
BAG3
JunD
γ-tubulin
EGFP-BAG3
BAG3 - +
FRO
- +
MCF7
- +
U87
E F
BAG3
JunD
γ-tubulin
un
tra
ns
fec
ted
sc
ra
m
ble
sh
BA
G3
#1
sh
BA
G3
#2
sh
BA
G3
#3
sh
BA
G3
#4
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3352 C. Li et al. / Biochimica et Biophysica Acta 1833 (2013) 3346–3354mRNA of JunD. This connection indicates a counter-balancing feedback
loop may exist in which induction of BAG3 by c-Jun stabilizes JunD
that is then able to suppress AP-1.
JunD is the most broadly expressed member of the Jun family and
the AP-1 transcription factor complex, which plays distinct roles
dependent on cellular context and other factors, including the identity
of its partner in the AP-1 dimer, the presence or absence of JunD post-
transcriptional and post-translational regulators. The activity of JunD
is integrated into a regulatory network by which JunD exerts a pivotal
role in cellular growth control, such as cellular differentiation, pro-
liferation and apoptosis [25,40]. Increasing evidence indicates that
JunD gene expression is controlled by various factors through different
mechanisms. Although BAG3 did not affect the rate of transcription of
the JunD gene, it signiﬁcantly increased the stability of JunD mRNA.
This prolonged half-life of JunD mRNA leads to mRNA accumulation,
which is paralleled by an increase in JunD protein expression. The data
from the current studies show that BAG3 positively regulate post-
transcription but not transcription of the JunD gene. This positive
post-transcriptional regulation of the JunD gene by BAG3 is of biological
signiﬁcance because BAG3 promotes growth arrest induced by serum
deprivation via JunD. The observation that JunD plays a negative role
in the cell survival is not surprising, because several studies using
different approaches have suggested that JunD is a negative regulatorof proliferation [17,30,41,42]. Ectopic overexpression of JunD inhibits
cell proliferation [29,30,42], whereas JunD deﬁciency stimulates
cell proliferation likely as a consequence of increased cyclin D1 ex-
pression [43]. The current study demonstrated that BAG3 exert
antiproliferative effect upon serum starvation through the cell cycle
arrest at the G2-M transition via stabilizing JunD mRNA. Speciﬁcally,
in line with the present study, it has been reported that △9-
tetrahydrocannabinol (THC) induces cell-cycle arrest at the G2-M
transition via JunD activation [44]. As JunD plays a pivotal role in
balancing cell proliferation, differentiation and apoptosis, and the
association of JunDdysregulationwith several neoplasms andmetabolic
diseases, the observation that BAG3 regulates JunD expression merits
further investigation.
BAG3 is involved in a number of cellular processes, including cell
proliferation, apoptosis, angiogenesis, autophagy, adhesion and migra-
tion [45]. Induction of BAG3 generally confers protection against
apoptosis while decrease in its expression promotes cell death in various
human cell models [11,14,22,46–48]. It therefore seems that induction of
BAG3 is a protectivemechanism in anti-stress responses. Counterintuitive
for an image of stress-inducible gene, however, the current study
reported that during stress of serum starvation, BAG3 is downregulated
via reduction of c-Jun at the transcriptional level. Furthermore, the
current study demonstrated blockade of BAG3 downregulation promotes
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Fig. 5. Implication of JunD in anti-proliferative effects of BAG3 during serum deprivation. A–B, Stable ectopic BAG3-expressing FRO (FRO-BAG3) cells were transfectedwith control siRNA
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3353C. Li et al. / Biochimica et Biophysica Acta 1833 (2013) 3346–3354growth inhibition induced by serum deprivation. In line with the
current study, it has been reported that BAG3 induces growth
inhibition and differentiation of HL-60 cells [49]. The functions of
AP-1 transcription factor family depend on the cellular context, the
nature of the stimulus and the particular AP-1 member considered.
Thus, the intricate association of BAG3 with the Jun proteins might
partly ascribe to multifaceted functions of BAG3.
In conclusion, the current study implies a role of BAG3 located in a
counter-balancing feedback loop of AP-1. Further experiments will be
required to conﬁrm the effects of BAG3 in the transcriptional activities
of AP-1 proteins.
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